70 related articles for article (PubMed ID: 22629824)
21. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
22. [Tumor markers in patients with head-neck carcinomas].
Walther EK; Dahlmann N; Gorgulla HT
Laryngorhinootologie; 1990 May; 69(5):271-4. PubMed ID: 2354022
[TBL] [Abstract][Full Text] [Related]
23. Personalizing cancer care: updates on head and neck cancer.
de Souza JA; Cohen EE
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
[TBL] [Abstract][Full Text] [Related]
24. Head and neck squamous cell carcinoma skin metastases below of the diaphragm.
Danić D; Danić A
Acta Dermatovenerol Croat; 2003; 11(3):153-7. PubMed ID: 12967507
[TBL] [Abstract][Full Text] [Related]
25. HER2 expression predicts improved survival in patients with cervical node-positive head and neck squamous cell carcinoma.
Tse GM; Yu KH; Chan AW; King AD; Chen GG; Wong KT; Tsang RK; Chan AB
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):467-73. PubMed ID: 19786214
[TBL] [Abstract][Full Text] [Related]
26. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
Wolf GT; Carey TE
J Natl Cancer Inst Monogr; 1992; (13):67-74. PubMed ID: 1389697
[TBL] [Abstract][Full Text] [Related]
27. Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial.
Alkureishi LW; Ross GL; Shoaib T; Soutar DS; Robertson AG; Thompson R; Hunter KD; Sorensen JA; Thomsen J; Krogdahl A; Alvarez J; Barbier L; Santamaria J; Poli T; Sesenna E; Kovács AF; Grünwald F; Barzan L; Sulfaro S; Alberti F
Ann Surg Oncol; 2010 Sep; 17(9):2459-64. PubMed ID: 20552410
[TBL] [Abstract][Full Text] [Related]
28. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
29. [Parotid gland as the main site of metastasis of the cutaneous squamous cell carcinoma of the head].
Teymoortash A
Laryngorhinootologie; 2007 Oct; 86(10):699-704. PubMed ID: 17879900
[TBL] [Abstract][Full Text] [Related]
30. Role of metalloproteins in the clinical management of head and neck squamous cell carcinoma.
Scurry WC; Stack BC
Head Neck; 2007 Dec; 29(12):1144-55. PubMed ID: 17657798
[TBL] [Abstract][Full Text] [Related]
31. Lymphatic vessel density, nodal metastases, and prognosis in patients with head and neck cancer.
Audet N; Beasley NJ; MacMillan C; Jackson DG; Gullane PJ; Kamel-Reid S
Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1065-70. PubMed ID: 16365219
[TBL] [Abstract][Full Text] [Related]
32. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance.
Kim SH; Lee SY; Park HR; Sung JM; Park AR; Kang S; Kim BG; Choi YP; Kim YB; Cho NH
Cancer; 2011 May; 117(9):1864-73. PubMed ID: 21509763
[TBL] [Abstract][Full Text] [Related]
33. Renal metastasis of head and neck squamous cell carcinoma with inferior vena caval thrombus.
Unni R; Wahle GR; Scott JW
J Urol; 2004 Mar; 171(3):1236. PubMed ID: 14767312
[No Abstract] [Full Text] [Related]
34. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
[TBL] [Abstract][Full Text] [Related]
35. Stem cells in head and neck squamous cell carcinoma.
Shakib K; Schrattenholz A; Soskic V
Br J Oral Maxillofac Surg; 2011 Oct; 49(7):503-6. PubMed ID: 20832149
[TBL] [Abstract][Full Text] [Related]
36. Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.
Nijkamp MM; Hoogsteen IJ; Span PN; Takes RP; Lok J; Rijken PF; van der Kogel AJ; Bussink J; Kaanders JH
Radiother Oncol; 2011 Oct; 101(1):165-70. PubMed ID: 21775008
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of GLUT-1 immunoreactivity to distinguish benign from malignant cystic squamous lesions of the head and neck in fine-needle aspiration biopsy material.
Weiner MF; Miranda RN; Bardales RH; Mukunyadzi P; Baker SJ; Korourian S; De Las Casas LE
Diagn Cytopathol; 2004 Nov; 31(5):294-9. PubMed ID: 15468132
[TBL] [Abstract][Full Text] [Related]
38. [Effect of tissue inhibitors of metalloproteinases (TIMP) on course and prognosis of head and neck squamous cell carcinoma].
Klisho EV; Kondakova IV; Choĭnzonov EL; Shishkin DA; Cheremisina OV; Chuzhevskaia SIu
Vopr Onkol; 2009; 55(6):717-21. PubMed ID: 20210014
[TBL] [Abstract][Full Text] [Related]
39. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
Scher RL
Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613
[TBL] [Abstract][Full Text] [Related]
40. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
